RESEARCH-USE BIOSIMILAR ANTIBODY
Enuzovimab
Monoclonal antibody · IgG4
Enuzovimab (HFB-30132A) is a mAb against SARS-COV-2 Omicron. Enuzovimab binds to spike (S) protein with high affinity.
TARGETSARS-CoV-2 Spike RBD
YMonoclonal antibody
CATALOGSC-BS-577
CATALOG NUMBERSC-BS-577
MOLECULAR WEIGHTApprox. 144.117 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Enuzovimab (HFB-30132A) is a mAb against SARS-COV-2 Omicron. Enuzovimab binds to spike (S) protein with high affinity.
Enuzovimab is a recombinant research-use antibody directed against SARS-CoV-2 Spike RBD.